4.7 Review

Peripheral Nerve Injury: Stem Cell Therapy and Peripheral Nerve Transfer

期刊

出版社

MDPI AG
DOI: 10.3390/ijms17122101

关键词

regeneration; Schwann cells; nerve graft; axonal injury; combination therapy; growth factors

资金

  1. National Institutes of Health, National Institute of Neurological Disorders, and Stroke [1R01NS071956, 1R01NS090962, 1R21NS089851]
  2. Department of Defense [W81XWH-11-1-0634]
  3. James and Esther King Foundation for Biomedical Research Program
  4. SanBio Inc.
  5. KM Pharmaceuticals
  6. NeuralStem Inc
  7. Karyopharm Inc.

向作者/读者索取更多资源

Peripheral nerve injury can lead to great morbidity in those afflicted, ranging from sensory loss, motor loss, chronic pain, or a combination of deficits. Over time, research has investigated neuronal molecular mechanisms implicated in nerve damage, classified nerve injury, and developed surgical techniques for treatment. Despite these advancements, full functional recovery remains less than ideal. In this review, we discuss historical aspects of peripheral nerve injury and introduce nerve transfer as a therapeutic option, as well as an adjunct therapy to transplantation of Schwann cells and their stem cell derivatives for repair of the damaged nerve. This review furthermore, will provide an elaborated discussion on the sources of Schwann cells, including sites to harvest their progenitor and stem cell lines. This reflects the accessibility to an additional, concurrent treatment approach with nerve transfers that, predicated on related research, may increase the efficacy of the current approach. We then discuss the experimental and clinical investigations of both Schwann cells and nerve transfer that are underway. Lastly, we provide the necessary consideration that these two lines of therapeutic approaches should not be exclusive, but conversely, should be pursued as a combined modality given their mutual role in peripheral nerve regeneration.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据